Norbrook Laboratories announces Czech acquisition
Norbrook Laboratories of Newry, Northern Ireland, has acquired the Procaine Hydrochloride and Benzocaine Division of Aliachem a.s., Division Synthesia, in Pardubice, Czech Republic for an undisclosed £Stg multi-million sum.
Norbrook is a world leader in the pharmaceutical industry and is a major producer of a number of pharmaceutical active ingredients. The company's main synthesis operations are in Ireland with a research division based in Carlisle, England. This new acquisition will enhance the company's portfolio of bulk pharmaceuticals.
The Chairman of Norbrook Laboratories, Lord Ballyedmond, has expressed his pleasure at the acquisition:
"Synthesia is a company with an excellent history and a lot of expertise. It will be synergistic with our present operations and we hope to increase production in this excellent facility based in Pardubice in the Czech Republic"
(3)
(1)
(2)
